Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Julia Martinez-Perez"'
Autor:
M C Fernández-Fernández, Amancio Carnero, Maria Jose Ortiz, Julia Martinez-Perez, Javier Peinado-Serrano, Maria Rivero, Sandra Muñoz-Galván, José M. García-Heredia
Publikováno v:
Cells
Volume 9
Issue 5
Digital.CSIC. Repositorio Institucional del CSIC
instname
idUS: Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)
idUS. Depósito de Investigación de la Universidad de Sevilla
Cells, Vol 9, Iss 1071, p 1071 (2020)
Volume 9
Issue 5
Digital.CSIC. Repositorio Institucional del CSIC
instname
idUS: Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)
idUS. Depósito de Investigación de la Universidad de Sevilla
Cells, Vol 9, Iss 1071, p 1071 (2020)
Colorectal cancer (CRC) is the third most common cancer worldwide. The standard treatment in locally advanced rectal cancer is preoperative radiation alone or in combination with chemotherapy, followed by adjuvant chemotherapy. Rectal cancer is highl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76c62a03970d56b1585c2672e3dddeaa
Publikováno v:
Expert opinion on drug safety. 17(6)
TAS102 is an oral thymidine-based nucleoside analog that has been approved for the treatment of patients with metastatic colorectal cancer (mCRC) previously treated with, or not candidates for, available therapies including fluoropyrimidine-, oxalipl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c7e766b5b06ba9db013df0a435f8fcd
https://pubmed.ncbi.nlm.nih.gov/29745737
https://pubmed.ncbi.nlm.nih.gov/29745737
Autor:
Marta Benavent, Javier Salamanca, María Luisa Limón, Iker Lopez-Calderero, Reyes Gonzalez-Exposito, Rocio Garcia-Carbonero, Amancio Carnero, Beatriz Soldevilla, Carmen Sáez, Maria C Riesco-Martinez, Julia Martinez-Perez
Publikováno v:
Human pathology. 67
Src belongs to a family of cytoplasmic tyrosine kinases that play a key role in tumor initiation and progression. Src activation has been associated with a more aggressive neoplastic phenotype and induces resistance to platinum agents in preclinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54a873cd5fd971e1e23f4b30f65e51a9
https://pubmed.ncbi.nlm.nih.gov/28601656
https://pubmed.ncbi.nlm.nih.gov/28601656
Autor:
Fernando Rivera, María Luisa Limón, Maria Dolores Pastor, Amancio Carnero, Marta Benavent, Sonia Molina-Pinelo, Julia Martinez-Perez, Purificacion Estevez-Garcia, J. Gomez, Rocio Garcia-Carbonero, Luis Paz-Ares
Publikováno v:
Oncotarget
Digital.CSIC. Repositorio Institucional del CSIC
instname
Digital.CSIC. Repositorio Institucional del CSIC
instname
Estévez-García, Purificación et al.
Fluoropyrimidine-based chemotherapy (CT) has been the mainstay of care of metastatic colorectal cancer (mCRC) for years. Response rates are only observed, however, in about half of treated patients, and the
Fluoropyrimidine-based chemotherapy (CT) has been the mainstay of care of metastatic colorectal cancer (mCRC) for years. Response rates are only observed, however, in about half of treated patients, and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f210113949c7d7d08e1eaa087d6cf64
https://pubmed.ncbi.nlm.nih.gov/25730906
https://pubmed.ncbi.nlm.nih.gov/25730906
Autor:
Sandra Muñoz-Galván, Maria Rivero, Javier Peinado-Serrano, Julia Martinez-Pérez, MC Fernández-Fernández, María José Ortiz, José M. García-Heredia, Amancio Carnero
Publikováno v:
Cells, Vol 9, Iss 5, p 1071 (2020)
Colorectal cancer (CRC) is the third most common cancer worldwide. The standard treatment in locally advanced rectal cancer is preoperative radiation alone or in combination with chemotherapy, followed by adjuvant chemotherapy. Rectal cancer is highl
Externí odkaz:
https://doaj.org/article/58c63dfec0804429a03d7ac6a751a61f